Boston Scientific Corporation vs Kraft Heinz Co — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Kraft Heinz Co trades at $24.63 (market cap $29.23B). The key difference: Boston Scientific Corporation is far larger — about 2.5× Kraft Heinz Co's market cap, and Kraft Heinz Co pays a 6.49% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | KHC | |
|---|---|---|
Market Cap | $74.19B | $29.23B |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $28.06 |
52-Week Low | $42.63 | $21.21 |
Enterprise Value | $86.27B | $45.55B |
Dividend Yield | — | 6.49% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →